Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19

References

• Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021;21(1):855. doi:10.1186/s12879-021-06536-3
   PubMed Web of Science ®Google Scholar
• Posso M, Comas M, Román M, et al. Comorbidities and mortality in patients with COVID-19 aged 6. years and older in a university hospital in Spain. Arch Bronconeumol. 2020;56(11):756–758. doi:10.1016/j.arbres.2020.06.012
   Web of Science ®Google Scholar
• Golpe R, Blanco N, Castro-an ̃ón O, et al. Factors associated to hospital admission in a care protocol in COVID-19. Arch Bronconeumol. 2020;56(10):676–677. doi:10.1016/j.arbres.2020.05.038
   PubMed Web of Science ®Google Scholar
• Zhang JJ, Dong X, Liu GH, Gao YD. Risk and protective factors for COVID-19 morbidity, severity, and mortality. Clin Rev Allergy Immunol. 2022;19:1–18.
   Google Scholar
• Tazerji SS, Shahabinejad F, Tokasi M, et al. Global data analysis and risk factors associated with morbidity and mortality of COVID-19. Gene Rep. 2022;26:101505. doi:10.1016/j.genrep.2022.101505
   PubMed Web of Science ®Google Scholar
• Graziani D, Soriano JB, Del Rio-Bermudez C, et al. Characteristics and Prognosis of COVID-19 in Patients with COPD. J Clin Med. 2020;9(10):3259. doi:10.3390/jcm9103259
   PubMed Web of Science ®Google Scholar
• Gerayeli FV, Milne S, Cheung C, et al. COPD and the risk of poor outcomes in COVID-19: a systematic review and meta-analysis. EClinicalMedicine. 2021;33:100789. doi:10.1016/j.eclinm.2021.100789
   PubMedGoogle Scholar
• Akbari A, Fathabadi A, Razmi M, et al. Characteristics, risk factors, and outcomes associated with readmission in COVID-19 patients: a systematic review and meta-analysis. Am J Emerg Med. 2022;52:166–173. doi:10.1016/j.ajem.2021.12.012
   PubMed Web of Science ®Google Scholar
• Lavery AM, Preston LE, Ko JY, et al. Characteristics of Hospitalized COVID-19 Patients Discharged and Experiencing Same-Hospital Readmission - United States, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(45):1695–1699. doi:10.15585/mmwr.mm6945e2
   PubMed Web of Science ®Google Scholar
• Ramos-Martínez A, Parra-Ramírez LM, Morrás I, et al. Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients. Sci Rep. 2021;11(1):13733. doi:10.1038/s41598-021-93076-0
   PubMed Web of Science ®Google Scholar
• Menéndez R, Méndez R, Latorre A, et al. Residual pulmonary infiltrates, symptoms and diffusion impairment at 1-year after severe COVID-19 infection have different associated factors. J Intern Med. 2023;294:69–82. doi:10.1111/joim.13642
   PubMed Web of Science ®Google Scholar
• R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2022. Available from: https://www.R-project.org/. Accessed November 4, 2023.
   Google Scholar
• Gómez Antúnez M, Muiño Míguez A, Bendala Estrada AD, et al.; SEMI-COVID-19 Network. Clinical Characteristics and Prognosis of COPD Patients Hospitalized with SARS-CoV-2. Int J Chronic Obstructive Pulmonary Dis. 2021;15:3433–3445. doi:10.2147/COPD.S276692
   PubMed Web of Science ®Google Scholar
• Hyams C, Qian G, Nava G, et al. Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults. J R Soc Med;2023. 1410768231184162. doi:10.1177/01410768231184162
   Web of Science ®Google Scholar
• Ramzi ZS. Hospital readmissions and post-discharge all-cause mortality in COVID-19 recovered patients; A systematic review and meta-analysis. Am J Emerg Med. 2022;51:267–279. doi:10.1016/j.ajem.2021.10.059
   PubMed Web of Science ®Google Scholar
• Freire MP, Oliveira MS, Magri MMC, et al. Frequency and factors associated with hospital readmission after COVID-19 hospitalization: the importance of post-COVID diarrhea. Clinics. 2022;77:100061. doi:10.1016/j.clinsp.2022.100061
   PubMed Web of Science ®Google Scholar
• Donnelly JP, Wang XQ, Iwashyna TJ, Prescott HC. Readmission and Death After Initial Hospital Discharge Among Patients With COVID-19 in a Large Multihospital System. JAMA. 2021;325(3):304–306. doi:10.1001/jama.2020.21465
   PubMed Web of Science ®Google Scholar
• Inghammar M, Engstrom G, Ljungberg B, Lofdahl CG, Roth A, Egesten A. Increased incidence of invasive bacterial disease in chronic obstructive pulmonary disease compared to the general population—A population based cohort study. BMC Infect Dis. 2014;14:163–170. doi:10.1186/1471-2334-14-163
   PubMed Web of Science ®Google Scholar
• Lin SH, Perng DW, Chen CP, et al. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease. Int J Chron Obstruct Pulmon Dis. 2016;11:3051–3058. doi:10.2147/COPD.S115137
   PubMed Web of Science ®Google Scholar
• Ambrosetti M, Ageno W, Spanevello A, Salerno M, Pedretti RF. Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD. Thromb Res. 2003;112(4):203–207. doi:10.1016/j.thromres.2003.12.003
   PubMed Web of Science ®Google Scholar
• Novelli L, Raimondi F, Carioli G, et al. One-year mortality in COVID-19 is associated with patients’ comorbidities rather than pneumonia severity. Respir Med Res. 2022;83:100976. doi:10.1016/j.resmer.2022.100976
   PubMedGoogle Scholar
• Oseran AS, Song Y, Xu J, et al. Long term risk of death and readmission after hospital admission with covid-19 among older adults: retrospective cohort study. BMJ. 2023;382:e076222.
   Google Scholar
• Fernández Villar A, Golpe Gómez R, González Montaos A, et al. The impact of the SARS-CoV-2 pandemic on the demographic, clinical and social profiles of patients admitted to the Pneumology Department for a COPD exacerbation. PLoS One. 2023;18(9):e0290156. doi:10.1371/journal.pone.0290156
   PubMedGoogle Scholar
• Fedeli U, Casotto V, Barbiellini Amidei C, Vianello A, Guarnieri G. COPD-Related Mortality before and after Mass COVID-19 Vaccination in Northern Italy. Vaccines. 2023;11(8):1392. doi:10.3390/vaccines11081392
   Web of Science ®Google Scholar
• Hyams C, Challen R, Marlow R, et al. Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study in Bristol. United Kingdom Lancet Reg Health Eur. 2023;25:100556. doi:10.1016/j.lanepe.2022.100556
   PubMedGoogle Scholar
• Van Goethem N, Chung PYJ, Meurisse M, et al. Clinical severity of SARS-CoV-2 Omicron variant compared with delta among hospitalized COVID-19 patients in Belgium during autumn and winter season 2021–2022. Viruses. 2022;14(6):1297. doi:10.3390/v14061297
   PubMed Web of Science ®Google Scholar
• Gómez-Antúnez M, Muiño-Míguez A, Bacete-Cebrián M, et al. Patients with COPD hospitalized due to COVID-19 in Spain: a comparison between the first and second wave. Rev Clin Esp. 2023;223(5):298–309. doi:10.1016/j.rce.2023.02.003
   Web of Science ®Google Scholar
• Lin L, Liu Y, Tang X, He D. The disease severity and clinical outcomes of the SARS-CoV-2 variants of concern. Front Public Health. 2021;9:775224. doi:10.3389/fpubh.2021.775224
   PubMed Web of Science ®Google Scholar